U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953869) titled 'Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia' on April 01.
Brief Summary: This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.
Study Start Date: April 21
Study Type: INTERVENTIONAL
Condition:
Insomnia Disorder
Intervention:
DRUG: Tasimelteon Oral Suspension
Single daily dose, weight-based liquid suspension formulation.
DRUG: Placebo
Placebo comparator.
Recruitment Status: RECRUITING
Sponsor: Vanda Pharmaceuticals
Published ...